1. Rising Prevalence of Cancer Is One of the Foremost Factors Driving the Exosomes Market
The rising prevalence of cancer is one of the major factors leading to increasing demand for exosomes. Several cell types, such as immune cells, mesenchymal cells, and cancer cells, release exosomes, associated with the tumor environment. Exosomes have the property of exerting an immunosuppressive function and can trigger an anti-tumor response by presenting tumor antigens to dendritic cells, therefore serving as essential cancer biomarkers for cancer treatment. Moreover, exosome derived from specific sites of the body are promising candidates for anti-cancer vaccines, due to its enhanced passive targeting, small size, indigenous nature, and the ability to cross biological barriers. Thus, the rising prevalence of cancer is an important factor for the growth of the exosome market.
2. Among Isolation Technologies, Ultracentrifugation is expected to dominate the Market
Within the scope of the study, the isolation technologies are segmented into ultracentrifugation, immunocapture on beads, precipitation, filtration, and others. Ultracentrifugation is expected to dominate the market. This exosome isolation method is considered as the gold standard and is one of the most commonly used and reported techniques for exosome isolation. The rise in the research of extracellular vesicles has also increased the demand for this isolation technique. It is highly cost-effective and reduces labor use, which increases the demand for it among the biopharmaceutical companies.
3. North America Expected to Dominate the Market
North America is expected to dominate the market, followed by the European region. The rising prevalence of cancer and the affordability among the public to adopt new techniques for cancer treatment are major drivers, as exosome offers high potential for cancer diagnostics. Innovation by several multinational companies is accelerating in the market, with high support from the government in form of useful funds. Further, several capital ventures, as well as universities and companies from the Eastern countries, are collaborating with multinational players, thus contributing to the growth of the market.
4. Leading Companies to Watch for
The report also examines the role of the leading players involved in the market. Some of the key players listed in the study are:
Danaher (Beckman Coulter, Inc.)
Fujifilm Holdings Corporation
Hitachi Chemical Diagnostics Inc.
Thermo Fisher Scientific Inc.
About Exosome Market
The Mordor Intelligence report estimates that the global exosome market is to register a CAGR of nearly 18.0% over the forecast period of 2018-2023, with rising prevalence of cancers, technological advancements in exosome isolation, analytical procedures, and funding driving the exosome market.
Mordor Intelligence is a market intelligence and advisory firm operating in 14 industry segments, serving over 600 clients across the world.